Annora Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANNORA
ANNORA has sixty-one approved drugs.
There are eight tentative approvals on ANNORA drugs.
Summary for Annora
| US Patents: | 0 |
| Tradenames: | 52 |
| Ingredients: | 52 |
| NDAs: | 61 |
| Patent Litigation for Annora: | See patent lawsuits for Annora |
Drugs and US Patents for Annora
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annora | LAMIVUDINE | lamivudine | TABLET;ORAL | 211306-001 | Mar 21, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Annora Pharma | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212277-001 | Jul 8, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Annora Pharma | IVABRADINE HYDROCHLORIDE | ivabradine hydrochloride | TABLET;ORAL | 213366-001 | Oct 5, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
